Literature DB >> 31321467

[Pituitary gland tumors].

K Karimian-Jazi1.   

Abstract

BACKGROUND: In this article, the most common pituitary gland tumors and the various differential diagnoses with focus on (neuro-)radiological diagnostic criteria are presented.
MATERIALS AND METHODS: An intensive, selective search of the literature in PubMed was carried out.
RESULTS: Pituitary adenomas account for approximately 10-15% of all intracranial brain tumors and are the most common tumors of the sellar region. Beyond a size of 10 mm they are called macroadenomas, under 10 mm microadenomas. They can be distinguished into hormone-active and non-active adenomas. Most of the hormone-active adenomas secrete prolactin (50%), more rarely somatotropin (10%) or corticotropin (5%). Tumors in the sellar region can arise from various tissues. Due to the anatomically complex location, local adjacent structures can be affected or compressed by the tumors. Particularly in case of suprasellar extension, visual impairment due to pressure on the optic chiasm is common. Important differential diagnoses for sellar tumors include craniopharyngiomas, meningiomas, metastases, aneurysms and Rathke cleft cysts. The task of image diagnostics is the early detection of the lesions as well as the proliferation pattern into perifocal structures. Gold standard is the thin-section, contrast-enhanced MRI examination. Dynamic contrast administration is crucial for the diagnosis of the microadenoma and the specific enhancement characteristic of some other tumors.
CONCLUSION: A highly focused imaging protocol is important for the diagnosis of sellar lesions such as pituitary tumors. The current favored modality is contrast-enhanced MRI, preferably with dynamic contrast-enhanced T1-weighted sequences. Early detection of the lesions and identification of the precise anatomical location are of great importance for diagnosis and therapy.

Entities:  

Keywords:  Adenoma; Differential diagnosis; Dynamic magnetic resonance imaging; Endocrinological symptoms; Sella turcica region

Mesh:

Year:  2019        PMID: 31321467     DOI: 10.1007/s00117-019-0570-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  25 in total

1.  MRI of intracranial chordomas. Extent of tumour and contrast enhancement: criteria for differential diagnosis.

Authors:  V Doucet; P Peretti-Viton; D Figarella-Branger; L Manera; G Salamon
Journal:  Neuroradiology       Date:  1997-08       Impact factor: 2.804

2.  MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium.

Authors:  A Tsunoda; O Okuda; K Sato
Journal:  AJNR Am J Neuroradiol       Date:  1997-03       Impact factor: 3.825

3.  Pituicytoma: A report of three cases and literature review.

Authors:  Xiaoyu Yang; Xiaoliang Liu; Wensen Li; Dawei Chen
Journal:  Oncol Lett       Date:  2016-09-12       Impact factor: 2.967

4.  Imaging the pituitary and parasellar region.

Authors:  Christopher P Hess; William P Dillon
Journal:  Neurosurg Clin N Am       Date:  2012-08-11       Impact factor: 2.509

Review 5.  Craniopharyngioma: a comparison of tumor control with various treatment strategies.

Authors:  Isaac Yang; Michael E Sughrue; Martin J Rutkowski; Rajwant Kaur; Michael E Ivan; Derick Aranda; Igor J Barani; Andrew T Parsa
Journal:  Neurosurg Focus       Date:  2010-04       Impact factor: 4.047

Review 6.  Pituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta-analysis of the world literature since 1893.

Authors:  M F Covington; S S Chin; A G Osborn
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

Review 7.  Imaging of sellar and parasellar lesions.

Authors:  Janine Rennert; Arnd Doerfler
Journal:  Clin Neurol Neurosurg       Date:  2006-11-28       Impact factor: 1.876

8.  A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively.

Authors:  A Gutenberg; J Larsen; I Lupi; V Rohde; P Caturegli
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-23       Impact factor: 3.825

Review 9.  Diagnosis and Treatment of Pituitary Adenomas: A Review.

Authors:  Mark E Molitch
Journal:  JAMA       Date:  2017-02-07       Impact factor: 56.272

Review 10.  Review of Surgical Anatomy of the Tumors Involving Cavernous Sinus.

Authors:  Silky Chotai; Yi Liu; Songtao Qi
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar
View more
  1 in total

1.  Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.

Authors:  David A Paul; Alejandra Rodrigue; Nicholas Contento; Sam Haber; Ricky Hoang; Redi Rahmani; Adnan Hirad; Ismat Shafiq; Zoë Williams; G Edward Vates
Journal:  PLoS One       Date:  2022-08-03       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.